Bioinvent International Ab Stock Shares Outstanding
| BINV Stock | SEK 44.60 1.10 2.41% |
BioInvent International AB fundamentals help investors to digest information that contributes to BioInvent International's financial success or failures. It also enables traders to predict the movement of BioInvent Stock. The fundamental analysis module provides a way to measure BioInvent International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioInvent International stock.
BioInvent |
BioInvent International AB Company Shares Outstanding Analysis
BioInvent International's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BioInvent International Shares Outstanding | 65.8 M |
Most of BioInvent International's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioInvent International AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, BioInvent International AB has 65.8 M of shares currently outstending. This is 63.55% lower than that of the Biotechnology sector and 38.42% lower than that of the Health Care industry. The shares outstanding for all Sweden stocks is 88.49% higher than that of the company.
BioInvent Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioInvent International's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioInvent International could also be used in its relative valuation, which is a method of valuing BioInvent International by comparing valuation metrics of similar companies.BioInvent International is currently under evaluation in shares outstanding category among its peers.
BioInvent Fundamentals
| Return On Equity | -0.0274 | |||
| Return On Asset | -0.0192 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 1.16 B | |||
| Shares Outstanding | 65.8 M | |||
| Shares Owned By Insiders | 11.10 % | |||
| Shares Owned By Institutions | 57.02 % | |||
| Price To Earning | (9.49) X | |||
| Price To Book | 1.40 X | |||
| Price To Sales | 7.25 X | |||
| Revenue | 19.38 M | |||
| Gross Profit | 19.38 M | |||
| EBITDA | (263.32 M) | |||
| Net Income | (278.44 M) | |||
| Cash And Equivalents | 28.46 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 21.53 M | |||
| Debt To Equity | 22.00 % | |||
| Current Ratio | 2.73 X | |||
| Book Value Per Share | 25.92 X | |||
| Cash Flow From Operations | (245.84 M) | |||
| Earnings Per Share | (4.55) X | |||
| Target Price | 81.0 | |||
| Number Of Employees | 93 | |||
| Beta | 0.3 | |||
| Market Capitalization | 1.99 B | |||
| Total Asset | 1.45 B | |||
| Working Capital | 28 M | |||
| Current Asset | 56 M | |||
| Current Liabilities | 28 M | |||
| Z Score | 55.2 | |||
| Net Asset | 1.45 B |
About BioInvent International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioInvent International AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioInvent International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioInvent International AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.